South Korea · Delayed Price · Currency is KRW Hanall Biopharma Company Description
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally.
The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids.
The company was founded in 1973 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 1973 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
Contact Details
Address: 43, Sangseodang 1-gil Daejeon South Korea | |
| Phone | 82 42 932 5997 |
Stock Details
| Ticker Symbol | 009420 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7009420001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Su-Jin Park | Co-Chief Executive Officer, Vice President and Director |
| Sean Jeong | President, Co-Chief Executive Officer and Director |
| Christopher W. Slavinsky | Chief Business Development and Legal Officer |
| Nam-Yong Cho | Senior Executive Director of Sales and Marketing and Senior Managing Director |
| Jae-Seung Yoon | C.V.O |
| Hye Kyung Ahn | Head of Research Division |
| SeongUn Kim | Head of Business Management Division |